CIK 0001728117
- Non-accelerated filer
- Smaller reporting company
Gossamer Bio, Inc.
Sign in to watch- Ticker
- GOSS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 475461709
- Phone
- +1 858-684-1300
- Business address
- 3115 MERRYFIELD ROW, SUITE 120, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 6 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-24 | Hasnain Faheem President & CEO | Grant or award · Pre-Funded Warrant (Right to Buy) | +166 | $1,000.00 | $166K | 166 |
| 2026-08-24 | Hasnain Faheem President & CEO | Grant or award · Stock Option (Right to Buy) | +5,800,051 | 5,800,051 | ||
| 2026-03-19 | Hasnain Faheem President & CEO | Returned to the company · Stock Option (Right to Buy) | −1,680,000 | 0 | ||
| 2026-03-19 | Hasnain Faheem President & CEO | Returned to the company · Stock Option (Right to Buy) | −1,540,000 | 0 | ||
| 2026-03-19 | Hasnain Faheem President & CEO | Returned to the company · Stock Option (Right to Buy) | −1,312,500 | 0 | ||
| 2026-03-19 | Hasnain Faheem President & CEO | Returned to the company · Stock Option (Right to Buy) | −437,500 | 0 | ||
| 2026-03-19 | Hasnain Faheem President & CEO | Returned to the company · Stock Option (Right to Buy) | −544,500 | 0 | ||
| 2026-03-19 | Hasnain Faheem President & CEO | Returned to the company · Stock Option (Right to Buy) | −544,500 | 0 | ||
| 2026-03-19 | Hasnain Faheem President & CEO | Returned to the company · Stock Option (Right to Buy) | −650,000 | 0 | ||
| 2026-03-19 | Hasnain Faheem President & CEO | Returned to the company · Stock Option (Right to Buy) | −325,000 | 0 | ||
| 2026-03-19 | Hasnain Faheem President & CEO | Returned to the company · Stock Option (Right to Buy) | −47,000 | 0 | ||
| 2026-03-19 | Hasnain Faheem President & CEO | Returned to the company · Stock Option (Right to Buy) | −43,500 | 0 | ||
| 2026-03-19 | Hasnain Faheem President & CEO | Grant or award · Stock Option (Right to Buy) | +1,680,000 | 1,680,000 | ||
| 2026-03-19 | Hasnain Faheem President & CEO | Grant or award · Stock Option (Right to Buy) | +1,540,000 | 1,540,000 | ||
| 2026-03-19 | Hasnain Faheem President & CEO | Grant or award · Stock Option (Right to Buy) | +1,312,500 | 1,312,500 | ||
| 2026-03-19 | Hasnain Faheem President & CEO | Grant or award · Stock Option (Right to Buy) | +437,500 | 437,500 | ||
| 2026-03-19 | Hasnain Faheem President & CEO | Grant or award · Stock Option (Right to Buy) | +544,500 | 544,500 | ||
| 2026-03-19 | Hasnain Faheem President & CEO | Grant or award · Stock Option (Right to Buy) | +544,500 | 544,500 | ||
| 2026-03-19 | Hasnain Faheem President & CEO | Grant or award · Stock Option (Right to Buy) | +650,000 | 650,000 | ||
| 2026-03-19 | Hasnain Faheem President & CEO | Grant or award · Stock Option (Right to Buy) | +325,000 | 325,000 |
Page 1 of 3 · 47 trades